BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10626350)

  • 1. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.
    Coluccia M; Nassi A; Boccarelli A; Giordano D; Cardellicchio N; Locker D; Leng M; Sivo M; Intini FP; Natile G
    J Inorg Biochem; 1999 Oct; 77(1-2):31-5. PubMed ID: 10626350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2[E-HN=C(OMe)Me]2].
    Coluccia M; Nassi A; Boccarelli A; Giordano D; Cardellicchio N; Intini FP; Natile G; Barletta A; Paradiso A
    Int J Oncol; 1999 Nov; 15(5):1039-44. PubMed ID: 10536190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.
    Coluccia M; Boccarelli A; Mariggiò MA; Cardellicchio N; Caputo P; Intini FP; Natile G
    Chem Biol Interact; 1995 Dec; 98(3):251-66. PubMed ID: 8548863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
    Boccarelli A; Coluccia M; Intini FP; Natile G; Locker D; Leng M
    Anticancer Drug Des; 1999 Jun; 14(3):253-64. PubMed ID: 10500500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
    Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
    J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pharmacology of polynuclear platinum anti-cancer agents.
    Roberts JD; Peroutka J; Farrell N
    J Inorg Biochem; 1999 Oct; 77(1-2):51-7. PubMed ID: 10626354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA modifications by antitumor trans-[PtCl2(E-iminoether)2].
    Zaludová R; Zákovská A; Kaspárkova J; Balcarová Z; Vrána O; Coluccia M; Natile G; Brabec V
    Mol Pharmacol; 1997 Sep; 52(3):354-61. PubMed ID: 9281596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M; Locker D; Giraud-Panis MJ; Schwartz A; Intini FP; Natile G; Pisano C; Boccarelli A; Giordano D; Coluccia M
    Mol Pharmacol; 2000 Dec; 58(6):1525-35. PubMed ID: 11093793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N; Kelland LR; Roberts JD; Van Beusichem M
    Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
    Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
    J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.
    Khazanov E; Barenholz Y; Gibson D; Najajreh Y
    J Med Chem; 2002 Nov; 45(24):5196-204. PubMed ID: 12431047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isomerization of platinum-coordinated iminoethers induced by spectator ligands: stabilization of the Z anti configuration.
    Giardina-Papa D; Intini FP; Pacifico C; Natile G
    Inorg Chem; 2013 Nov; 52(22):13058-67. PubMed ID: 24187992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel imino thioether complexes of platinum(II): synthesis, structural investigation, and biological activity.
    Sgarbossa P; Sbovata SM; Bertani R; Mozzon M; Benetollo F; Marzano C; Gandin V; Michelin RA
    Inorg Chem; 2013 May; 52(10):5729-41. PubMed ID: 23647564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
    Kido Y; Khokhar AR; Siddik ZH
    Anticancer Drugs; 1993 Apr; 4(2):251-8. PubMed ID: 8490203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.